TCG Crossover Management »

Dyne Therapeutics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $15M 1.7M 8.96
2023-06-30 $19M 1.7M 11.25
2023-03-31 $19M 1.7M 11.52

More positions owned by TCG Crossover Management

Structure Therapeutics Adrs (GPCR)
Cogent Biosciences Comm (COGT)
Geron Corp Comm (GERN)
AN2 Therapeutics Comm (ANTX)
Savara Comm (SVRA)
Taysha Gene Therapies Comm (TSHA)
Kalvista Pharmaceuticals Comm (KALV)
Inhibrx Comm (INBX)
Aerovate Therapeutics Comm (AVTE)
Icosavax Comm
Compass Pathways Adrs (CMPS)
Ventyx Biosciences Comm (VTYX)
Tyra Biosciences Comm (TYRA)
Madrigal Pharmaceuticals Comm (MDGL)
Silence Therapeutics Adrs (SLN)

View all positions for TCG Crossover Management

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
BlackRock
RA Capital Management
Citadel Advisors
MPM Asset Management
Vanguard Group
FMR
Henderson Group
Adage Capital Partners GP
VR Adviser
Sofinnova Ventures
Franklin Resources
Logos Global Management
Goldman Sachs Group

View all funds holding Dyne Therapeutics